SEVERANCE AGREEMENTSeverance Agreement • March 4th, 2022 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledMarch 4th, 2022 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into this 6th day of January 2015 (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and James Fong (the “Employee”).
AMENDMENT TO SEVERANCE AGREEMENTSeverance Agreement • March 4th, 2022 • Cti Biopharma Corp • Pharmaceutical preparations
Contract Type FiledMarch 4th, 2022 Company IndustryTHIS AMENDMENT (this “Amendment”) to the Severance Agreement dated January 6, 2015 (the “Agreement”) is made and entered into this 1st day of March, 2022 (the “Effective Date”), by and between CTI BioPharma Corp., a Delaware corporation (the “Company”), and James Fong (the “Employee”).